Related Experiment Videos
Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect
P M Piatti1, L D Monti, S N Davis
1Istituto Scientifico H. San Raffaele, Università di Milano, Italy.
Diabetologia
|January 1, 1996
Summary
Reducing non-esterified fatty acids (NEFA) improves glucose tolerance and muscle glucose uptake in type 2 diabetes. This study shows acipimox effectively lowers NEFA, enhancing glucose metabolism but not normalization of glucose storage.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Human Physiology
Background:
- Non-esterified fatty acids (NEFA) play a crucial role in glucose metabolism.
- Elevated NEFA levels are associated with insulin resistance in type 2 diabetes.
- Understanding NEFA's impact on glucose tolerance and muscle metabolism is vital.
Purpose of the Study:
- To investigate the acute effects of decreased NEFA levels on glucose tolerance.
- To assess the impact on muscle glucose uptake and indirect calorimetry.
- To evaluate these effects in lean, non-insulin-dependent diabetic subjects.
Main Methods:
- A randomized, placebo-controlled study involving ten lean type 2 diabetic subjects.
- Two oral glucose tolerance tests (OGTT) were conducted.
- Acipimox (lipolysis inhibitor) or placebo was administered 2 hours prior to OGTT.
Main Results:
- Acipimox significantly reduced NEFA, glycerol, and 3-hydroxybutyrate levels.
- Muscle lipid oxidation and non-oxidative glycolysis decreased with acipimox.
- Acipimox improved glucose tolerance, increased muscle glucose uptake relative to insulin, and enhanced glucose oxidation.
Conclusions:
- Acute reduction of NEFA levels enhances glucose tolerance and muscle glucose uptake in type 2 diabetes.
- Acipimox administration improves glucose oxidation and non-oxidative glycolysis.
- Despite metabolic improvements, normalizing glucose storage remains a challenge.